31 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
in a Quality Agreement established with each supplier and vendor. Training compliance is assessed as part of the Company’s annual audit. The Company
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
Becoming Effective — Mutual Conditions Precedent”.
“LSE” means the London Stock Exchange.
“Major Supplier” means (i) each supplier who was one (1 … to such suppliers as of the date of the Arrangement Agreement and (ii) each supplier involved in the conduct of any clinical trials operated by the Company
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
the meaning set forth in Section 6.1(c).
“LSE” means the London Stock Exchange.
“Major Supplier” has the meaning set forth in Section 34 of Schedule C … customer, supplier, or subcontractor in the ordinary course of business under the terms of any Contract to which the relevant party is a party or under
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
activities with contract manufacturing and clinical research organizations are mandated and specified in a Quality Agreement established with each supplier
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
payments when due, default under their agreements with us, become insolvent or declare bankruptcy, or a supplier may determine that it will no longer … deal with us as a customer. In addition, a customer or supplier could be adversely affected by any of the liquidity or other risks that are described
SUPPL
k7felvw lujk6vwwn
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
46n8 fwetd0sw945b
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
ooa05j2e fw
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.2
3mmpvoh lcu
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
6-K
EX-99.2
sol53d ln0
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
6-K
EX-99.1
j98r5y81c
23 Dec 20
Open Market Sale Agreementsm
5:06pm
6-K
EX-99.1
aaxgaxu6vp9w zngtans
20 Oct 20
As Representatives of the several Underwriters
4:43pm
SUPPL
327tm060d347pp3rsk
5 Sep 19
Supplemental materials (foreign)
3:52pm
F-10/A
EX-3.1
gqd0p8
4 Sep 19
Registration of securities (Canada) (amended)
4:44pm
F-10
coz0v8
3 Sep 19
Registration of securities (Canada)
7:53am
6-K
EX-99.1
8xh 1lvo6m6
30 Apr 09
Current report (foreign)
12:00am
6-K
EX-99.2
x4godmmublhcvi
30 Apr 09
Current report (foreign)
12:00am
40-F
EX-99.1
zrdihul
14 Mar 08
Annual report (Canada)
12:00am
F-10/A
tx1t2 fz9ma8qlz7n
23 May 07
Registration of securities (Canada) (amended)
12:00am
F-10
2pya7w
9 May 07
Registration of securities (Canada)
12:00am